Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 137
1.
Sci Rep ; 10(1): 9023, 2020 06 02.
Article En | MEDLINE | ID: mdl-32488074

Cardiovascular disease (CVD) is the major cause of morbidity, mortality, and health care costs in the United States, and possibly around the world. Among the various risk factors of CVD, environmental and dietary exposures to mercury (Hg), a highly toxic metal traditionally regarded as a neurotoxin, has been recently suggested as a potential contributor towards human atherosclerotic development. In this study, we investigated the toxicity, type of cell death, dose-dependent uptake, and efflux of inorganic HgII (as HgCl2) and methylmercury or MeHg (as CH3HgCl) in EA.hy926 endothelial cells, as these two forms of Hg are often reported to be present in human blood among the general populations (~20-30% as HgII and ~70-80% as MeHg). Our results showed that HgII is more toxic than MeHg to the endothelial cells, owing to the higher uptake into the cytoplasm and perhaps importantly lower efflux of HgII by the cells, thus the "net" accumulation by the endothelial cells is higher for HgII than MeHg when exposed to the same Hg levels in the media. Furthermore, both HgII and MeHg were found to induce apoptotic and necrotic cell death. This study has important implications for the contributions of these two common Hg species to the development of atherosclerosis, an important process leading to CVD.


Endothelial Cells/drug effects , Mercuric Chloride/toxicity , Methylmercury Compounds/toxicity , Apoptosis/drug effects , Cell Death/drug effects , Cell Line , Dose-Response Relationship, Drug , Endothelial Cells/pathology , Endothelium, Vascular/cytology , Humans , Mercuric Chloride/administration & dosage , Mercuric Chloride/pharmacokinetics , Mercury/pharmacokinetics , Methylmercury Compounds/administration & dosage , Methylmercury Compounds/pharmacokinetics
2.
Food Chem Toxicol ; 135: 110939, 2020 Jan.
Article En | MEDLINE | ID: mdl-31697969

The effects of foliar Se biofortification (Se+) of the lettuce on the transfer and toxicity of Hg from soil contaminated with HgCl2 (H) and soil collected near the former Hg smelter in Idrija (I), to terrestrial food chain are explored, with Spanish slug as a primary consumer. Foliar application of Se significantly increased Se content in the lettuce, with no detected toxic effects. Mercury exerted toxic effects on plants, decreasing plant biomass, photochemical efficiency of the photosystem II (Fv/Fm) and the total chlorophyll content. Selenium biofortification (Se+ test group) had no effect on Hg bioaccumulation in plants. In slugs, different responses were observed in H and I groups; the I/Se+ subgroup was the most strongly affected by Hg toxicity, exhibiting lower biomass, feeding and growth rate and a higher hepatopancreas/ muscle Hg translocation, pointing to a higher Hg mobility in comparison to H group. Selenium increased Hg bioavailability for slugs, but with opposite physiological responses: alleviating stress in H/Se+ and inducing it in I/Se+ group, indicating different mechanisms of Hg-Se interactions in the food chain under HgCl2 and Idrija soil exposures that can be mainly attributed to different Hg speciation and ligand environment in the soil.


Biofortification/methods , Food Chain , Gastropoda/metabolism , Lactuca/metabolism , Mercury/toxicity , Selenium/pharmacology , Animals , Bioaccumulation , Biological Availability , Environmental Pollutants/pharmacokinetics , Environmental Pollutants/toxicity , Mercuric Chloride/pharmacokinetics , Mercuric Chloride/toxicity , Mercury/pharmacokinetics , Soil/chemistry
3.
Environ Toxicol Pharmacol ; 45: 8-14, 2016 Jul.
Article En | MEDLINE | ID: mdl-27218434

A 2×3 factorial design was employed to evaluate the effects of dietary vitamin C (l-ascorblyl-2-monophosphate, C2MP) levels on growth and tissue mercury (Hg) accumulations in juvenile olive flounder, Paralichthys olivaceus. Six experimental diets with two levels of mercuric chloride (0 or 20mg HgCl2/kg diet) and three levels of vitamin C (0, 100, or 200mg C2MP/kg diet) were added to the basal diet. At the end of 6 weeks feeding trial, in presence or absence of dietary Hg, fish body weight gain, specific growth rate, feed efficiency, protein efficiency ratio and whole body lipid content were increased in a dose-dependent manner as dietary vitamin C level increased in the diets. Interestingly, fish fed 100 or 200mg C2MP/kg diets showed significant interactive effects on reducing Hg content in kidney tissue. These results revealed that dietary vitamin C as 100 or 200mg C2MP/kg diet had protective effect against Hg accumulation in juvenile olive flounder.


Ascorbic Acid/pharmacology , Mercuric Chloride/pharmacokinetics , Animals , Ascorbic Acid/pharmacokinetics , Diet , Fish Proteins/metabolism , Flounder/growth & development , Flounder/metabolism , Kidney/metabolism , Lipid Metabolism/drug effects , Liver/metabolism , Mercuric Chloride/toxicity , Muscles/metabolism , Weight Gain/drug effects
4.
Regul Toxicol Pharmacol ; 76: 51-6, 2016 Apr.
Article En | MEDLINE | ID: mdl-26804582

Traditional Chinese medicines (TCM) are increasingly being used as alternative medicines in many countries, and this has caused concern because of adverse health effects from toxic metal bioavailability such as mercury (Hg) and arsenic (As). The aim of this study was to investigate the bioavailability of As and Hg from TCM after a single exposure dose using an animal model of female Sprague-Dawley rats. The rats were divided into 6 groups which included four groups treated with sodium arsenite (NaAsO2), arsenic sulfide (As2S3), mercuric chloride (HgCl2), mercuric sulfide (HgS), and two groups treated with TCM containing high Hg or As (Liu Shen Wan: As 7.7-9.1% and Hg 1.4-5.0%; Niuhang Jie du Pian: As 6.2-7.9% and Hg <0.001%). The samples of urine, faeces, kidney and liver were collected for analysis and histological assay. The results indicated that relatively low levels of As and Hg from these TCM were retained in liver and kidney tissues. The levels of As in these tissues after TCM treatment were consistent with the levels from the As sulphide treated group. With the exception of the mercuric chloride treated group, the levels of Hg in urine from other groups were very low, and high levels of As and Hg from TCM were excreted in faeces. The study showed poor bioavailability of As and Hg from TCM as indicated by low relative bioavailability of As (0.60-1.10%) and Hg (<0.001%). Histopathological examination of rat kidney and liver tissues did not show toxic effects from TCM.


Arsenicals/pharmacokinetics , Arsenites/pharmacokinetics , Drug Contamination , Drugs, Chinese Herbal/pharmacokinetics , Mercuric Chloride/pharmacokinetics , Mercury Compounds/pharmacokinetics , Sodium Compounds/pharmacokinetics , Sulfides/pharmacokinetics , Administration, Oral , Animals , Arsenicals/administration & dosage , Arsenicals/urine , Arsenites/administration & dosage , Arsenites/toxicity , Arsenites/urine , Biological Availability , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/toxicity , Feces/chemistry , Female , Kidney/drug effects , Kidney/metabolism , Liver/drug effects , Liver/metabolism , Mercuric Chloride/administration & dosage , Mercuric Chloride/toxicity , Mercuric Chloride/urine , Mercury Compounds/administration & dosage , Mercury Compounds/toxicity , Mercury Compounds/urine , Rats, Sprague-Dawley , Risk Assessment , Sodium Compounds/administration & dosage , Sodium Compounds/toxicity , Sodium Compounds/urine , Sulfides/administration & dosage , Sulfides/toxicity , Sulfides/urine , Tissue Distribution
5.
Exp Gerontol ; 75: 16-23, 2016 Mar.
Article En | MEDLINE | ID: mdl-26768998

Aging often results in progressive losses of functioning nephrons, which can lead to a significant reduction in overall renal function. Because of age-related pathological changes, the remaining functional nephrons within aged kidneys may be unable to fully counteract physiological and/or toxicological challenges. We hypothesized that when the total functional renal mass of aged rats is reduced by 50%, the nephrons within the remnant kidney do not fully undergo the functional and physiological changes that are necessary to maintain normal fluid and solute homeostasis. We also tested the hypothesis that the disposition and handling of a nephrotoxicant are altered significantly in aged kidneys following an acute, 50% reduction in functional renal mass. To test these hypotheses, we examined molecular indices of renal cellular hypertrophy and the disposition of inorganic mercury (Hg(2+)), a model nephrotoxicant, in young control, young uninephrectomized (NPX), aged control and aged NPX Wistar rats. We found that the process of aging reduces the ability of the remnant kidney to undergo compensatory renal growth. In addition, we found that an additional reduction in renal mass in aged animals alters the disposition of Hg(2+) and potentially alters the risk of renal intoxication by this nephrotoxicant. To our knowledge, this study represents the first report of the handling of a nephrotoxicant in an aged animal following a 50% reduction in functional renal mass.


Aging/pathology , Kidney/pathology , Mercuric Chloride/pharmacokinetics , Aging/metabolism , Animals , Creatinine/blood , Disease Models, Animal , Hypertrophy/metabolism , Hypertrophy/pathology , Kidney/metabolism , Male , Nephrectomy , Organ Size , Oxidative Stress/physiology , Rats, Wistar
6.
Toxicology ; 335: 62-71, 2015 Sep 01.
Article En | MEDLINE | ID: mdl-26196528

Environmental toxicants such as methylmercury have been shown to negatively impact fetal health. Despite the prevalence of inorganic mercury (Hg(2+)) in the environment and the ability of methylmercury to biotransform into Hg(2+), little is known about the ability of Hg(2+) to cross the placenta into fetal tissues. Therefore, it is important to understand the handing and disposition of Hg(2+) in the reproductive system. The purpose of the current study was to assess the disposition and transport of Hg(2+) in placental and fetal tissues, and to test the hypothesis that acute renal injury in dams can alter the accumulation of Hg(2+) in fetal tissues. Pregnant Wistar rats were injected intravenously with 0.5 or 2.5 µmol kg(-1) HgCl2 for 6 or 48 h and the disposition of Hg(2+) was measured. Accumulation of Hg(2+) in the placenta was rapid and dose-dependent. Very little Hg(2+) was eliminated during the initial 48 h after exposure. When dams were exposed to the low dose of HgCl2, fetal accumulation of Hg(2+) increased between 6h and 48 h, while at the higher dose, accumulation was similar at each time point. Within fetal organs, the greatest concentration of Hg(2+) (nmol/g) was localized in the kidneys, followed by the liver and brain. A dose-dependent increase in the accumulation of Hg(2+) in fetal organs was observed, suggesting that continued maternal exposure may lead to increased fetal exposure. Taken together, these data indicate that Hg(2+) is capable of crossing the placenta and gaining access to fetal organs in a dose-dependent manner.


Environmental Pollutants/pharmacokinetics , Fetus/metabolism , Maternal-Fetal Exchange , Mercuric Chloride/pharmacokinetics , Placenta/metabolism , Animals , Animals, Newborn , Brain/metabolism , Dose-Response Relationship, Drug , Environmental Pollutants/administration & dosage , Environmental Pollutants/blood , Environmental Pollutants/toxicity , Feces/chemistry , Female , Injections, Intravenous , Kidney/metabolism , Kidney Diseases/chemically induced , Liver/metabolism , Maternal Exposure , Mercuric Chloride/administration & dosage , Mercuric Chloride/blood , Mercuric Chloride/toxicity , Permeability , Pregnancy , Rats, Wistar , Risk Assessment , Tissue Distribution
7.
Mar Pollut Bull ; 97(1-2): 488-493, 2015 Aug 15.
Article En | MEDLINE | ID: mdl-26026249

The goal of this work was to understand the extent of mercury toxic effects in liver metabolism under an episode of acute contamination. Hence, the effects of in vitro mercuric chloride in liver mitochondria were assessed in two commercial marine fish: Senegalese sole (Solea senegalensis) and gilthead seabream (Sparus aurata). Liver mitochondria were exposed to 0.2mgL(-1) of mercury, the average concentration found in fish inhabiting contaminated areas. Mercuric chloride depressed mitochondrial respiration state 3 and the maximal oxygen consumption in the presence of FCCP indicating inhibitory effects on the oxidative phosphorylation and on the electron transport chain, respectively. The inhibition of F1Fo-ATPase and succinate-dehydrogenase activities also corroborated the ability of mercury to inhibit ADP phosphorylation and the electron transport chain. This study brings new understanding on the mercury levels able to impair fish mitochondrial function, reinforcing the need for further assessing bioenergetics as a proxy for fish health status.


Energy Metabolism/drug effects , Flatfishes/metabolism , Mercuric Chloride/toxicity , Mitochondria, Liver/drug effects , Sea Bream/metabolism , Water Pollutants, Chemical/toxicity , Animals , Mercuric Chloride/pharmacokinetics , Mitochondria, Liver/enzymology , Mitochondria, Liver/metabolism , Oxidation-Reduction , Oxidative Phosphorylation , Oxygen Consumption/drug effects , Toxicity Tests , Water Pollutants, Chemical/pharmacokinetics
8.
J Fluoresc ; 24(4): 1313-7, 2014 Jul.
Article En | MEDLINE | ID: mdl-24912450

In the present study, we used the previously developed fluorescence probe, EPNP, to generate the first image of the distribution of mercuric ion in primary mouse neuron cultures. At postnatal day 1 (P1), the mice were intraperitoneally (IP) injected with mercuric chloride in doses ranging from 0.05 to 0.6 µg/g body weight. After 1, 2, 3, and 4 days exposure, primary nervous cell cultures and frozen brain and spinal tissue sections were prepared and dyed using EPNP. On the third day of repeated injections, Hg(2+) was visualized in primary cerebral neuron cultures as an increase of Hg(2+)-induced fluorescence at the doses ≥ 0.1 µg/g. A similar accumulation of Hg(2+) was observed in frozen hippocampus tissue sections. In contrast, no Hg(2+) was observed in spinal cord neurons and spinal tissue sections. The detection of a low dose of IP injected mercury in mouse cerebral neurons facilitated the evaluation of the exposure risk to low-dose Hg(2+) in immature organisms. Moreover, the highly sensitive EPNP revealed Hg(2+) in the cerebral neurons of mice younger than P4, while the presence of Hg(2+) was not detected until ≥ P11 in previous reports. Thus, this technology and the results obtained herein are of interest for neurotoxicology.


Fluorescent Dyes/analysis , Mercury/analysis , Neurons/chemistry , Animals , Cells, Cultured , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/chemistry , Injections, Intraperitoneal , Mercuric Chloride/administration & dosage , Mercuric Chloride/chemistry , Mercuric Chloride/pharmacokinetics , Mercury/administration & dosage , Mercury/pharmacokinetics , Mice , Neurons/metabolism , Time Factors , Tissue Distribution
9.
Indian J Med Res ; 139(4): 610-8, 2014 Apr.
Article En | MEDLINE | ID: mdl-24927349

BACKGROUND & OBJECTIVES: Sidh Makardhwaj (SM) is a mercury based Ayurvedic formulation used in rheumatoid arthritis and neurological disorders. However, toxicity concerns due to mercury content are often raised. Therefore, the present study was carried out to evaluate the effect of SM on brain cerebrum, liver and kidney in rats. METHODS: Graded doses of SM (10, 50, 100 mg/kg), mercuric chloride (1 mg/kg) and normal saline were administered orally to male Wistar rats for 28 days. Behavioural parameters were assessed on days 1, 7, 14 and 28 using Morris water maze, passive avoidance, elevated plus maze and rota rod. Liver and kidney function tests were done on day 28. Animals were sacrificed and brain cerebrum acetylcholinesterase activity, levels of malondialdehyde (MDA), reduced glutathione (GSH) in brain cerebrum, liver, kidney were estimated. The levels of mercury in brain cerebrum, liver and kidney were estimated and histopathology of these tissues was also performed. RESULTS: SM in the doses used did not cause significant change in neurobehavioural parameters, brain cerebrum AChE activity, liver (ALT, AST, ALP bilirubin) and kidney (serum urea and creatinine) function tests as compared to control. The levels of mercury in brain cerebrum, liver, and kidney were found to be raised in dose dependent manner. However, the levels of MDA and GSH in these tissues did not show significant changes at doses of 10 and 50 mg/kg. Also, there was no histopathological change in cytoarchitecture of brain cerebrum, liver, and kidney tissues at doses of 10 and 50 mg/kg. INTERPRETATION & CONCLUSIONS: The findings of the present study suggest that Sidh Makardhwaj upto five times the equivalent human dose administered for 28 days did not show any toxicological effects on rat brain cerebrum, liver and kidney.


Cerebrum/drug effects , Kidney/drug effects , Liver/drug effects , Medicine, Ayurvedic , Mercuric Chloride/pharmacokinetics , Mercuric Chloride/toxicity , Acetylcholinesterase/metabolism , Administration, Oral , Analysis of Variance , Animals , Glutathione/drug effects , Male , Malondialdehyde/metabolism , Maze Learning/drug effects , Mercuric Chloride/administration & dosage , Rats , Rotarod Performance Test , Time Factors
10.
Exp Gerontol ; 53: 31-9, 2014 May.
Article En | MEDLINE | ID: mdl-24548775

Progressive loss of functioning nephrons, secondary to age-related glomerular disease, can impair the ability of the kidneys to effectively clear metabolic wastes and toxicants from blood. Additionally, as renal mass is diminished, cellular hypertrophy occurs in functional nephrons that remain. We hypothesize that these nephrons are exposed to greater levels of nephrotoxicants, such as inorganic mercury (Hg(2+)), and thus are at an increased risk of becoming intoxicated by these compounds. The purpose of the present study was to characterize the effects of aging on the disposition and renal toxicity of Hg(2+) in young adult and aged Wistar rats. Paired groups of animals were injected (i.v.) with either a 0.5µmol·kg(-1) non-nephrotoxic or a 2.5µmol·kg(-1) nephrotoxic dose of mercuric chloride (HgCl2). Plasma creatinine and renal biomarkers of proximal tubular injury were greater in both groups of aged rats than in the corresponding groups of young adult rats. Histologically, evidence of glomerular sclerosis, tubular atrophy, interstitial inflammation and fibrosis were significant features of kidneys from aged animals. In addition, proximal tubular necrosis, especially along the straight segments in the inner cortex and outer stripe of the outer medulla was a prominent feature in the renal sections from both aged and young rats treated with the nephrotoxic dose of HgCl2. Our findings indicate 1) that overall renal function is significantly impaired in aged rats, resulting in chronic renal insufficiency and 2) the disposition of HgCl2 in aging rats is significantly altered compared to that of young rats.


Aging/metabolism , Kidney/metabolism , Mercuric Chloride/pharmacokinetics , Renal Insufficiency, Chronic/chemically induced , Aging/pathology , Aging/physiology , Animals , Biomarkers/metabolism , Creatinine/blood , Dose-Response Relationship, Drug , Kidney/pathology , Kidney/physiopathology , Male , Mercuric Chloride/administration & dosage , Mercuric Chloride/toxicity , Rats , Rats, Wistar , Renal Insufficiency, Chronic/metabolism , Renal Insufficiency, Chronic/pathology
11.
J Med Toxicol ; 10(1): 40-4, 2014 Mar.
Article En | MEDLINE | ID: mdl-23760886

INTRODUCTION: Mercuric chloride poisoning is rare yet potentially life-threatening. We report a case of poisoning with a potentially significant amount of mercuric chloride which responded to aggressive management. CASE REPORT: A 19-year-old female presented to the Emergency Department with nausea, abdominal discomfort, vomiting of blood-stained fluid, and diarrhea following suicidal ingestion of 2-4 g of mercuric chloride powder. An abdominal radiograph showed radio-opaque material within the gastric antrum and the patient's initial blood mercury concentration was 17.9 µmol/L (or 3.58 mg/L) at 3 h post-ingestion. Given the potential toxicity of inorganic mercury, the patient was admitted to the intensive care unit and chelation with dimercaprol was undertaken. Further clinical effects included mild hemodynamic instability, acidosis, hypokalemia, leukocytosis, and fever. The patient's symptoms began to improve 48 h after admission and resolved fully within a week. DISCUSSION: Mercuric chloride has an estimated human fatal dose of between 1 and 4 g. Despite a reported ingestion of a potentially lethal dose and a high blood concentration, this patient experienced mild to moderate poisoning only and she responded to early and appropriate intervention. Mercuric chloride can produce a range of toxic effects including corrosive injury, severe gastrointestinal disturbances, acute renal failure, circulatory collapse, and eventual death. Treatment includes close observation and aggressive supportive care along with chelation, preferably with 2,3-dimercapto-1-propane sulfonate or 2,3-meso-dimercaptosuccinic acid.


Indicators and Reagents/toxicity , Mercuric Chloride/toxicity , Mercury Poisoning/drug therapy , Suicide, Attempted , Adult , Chelating Agents/administration & dosage , Chelating Agents/therapeutic use , Chelation Therapy , Dimercaprol/administration & dosage , Dimercaprol/therapeutic use , Female , Humans , Indicators and Reagents/chemistry , Indicators and Reagents/pharmacokinetics , Injections, Intramuscular , Mercuric Chloride/antagonists & inhibitors , Mercuric Chloride/pharmacokinetics , Mercury/blood , Mercury/chemistry , Mercury Poisoning/blood , Mercury Poisoning/therapy , Treatment Outcome , Young Adult
12.
Toxicol Sci ; 133(1): 101-11, 2013 May.
Article En | MEDLINE | ID: mdl-23392568

Developmental HgCl2 exposures of F1 offspring (H-2(q/s)) from unsociable SJL/J (H-2(s)) dams with high susceptibility to Hg-induced autoimmunity (SFvF1) and from highly sociable FVB/NJ (FVB; H-2(q)) dams with lower susceptibility to Hg-induced autoimmunity (FvSF1) were investigated. Hg exposure increased the serum IgG levels of all offspring at postnatal day 21 (pnd21) and of SJL/J dams but not of FVB dams. Serum IgG anti-brain antibody (Ab) levels of pnd21 SFvF1 offspring and SJL dams were higher than those of the FvSF1 offspring and FVB dams, but Hg only increased the titers of the FVB dams and their offspring. Hg significantly elevated the presence of IgG in all brain regions of the pnd21 SFvF1 offspring, and the SFvF1 offspring had greater amounts of IgG in the brain than the FvSF1 offspring, which had Hg-induced increases in only two brain regions. Cytokine levels were elevated in the brain regions of Hg-treated pnd21 SFvF1 but not of FvSF1 offspring, and SFvF1 females had more brain regions expressing cytokines than the males. At pnd70, the serum IgG, serum antibrain Abs, amounts of brain IgG, and brain cytokine levels of all of the Hg-treated offspring were equivalent to those of their appropriate controls, suggesting that developmental Hg exposure did not induce chronic immunological effects. However, the social behaviors of Hg-exposed SFvF1 offspring at pnd70 were significantly impaired, and SFvF1 females displayed greater decline in social behaviors than males, suggesting that the higher neuroinflammation of SFvF1 females earlier in life is associated with the altered behavior. Thus, developmental Hg exposure induces long-lasting effects on social behavior of offspring, which is dependent on sex and genetics and the induction of neuroinflammation.


Brain , Immunity/drug effects , Maternal Exposure/adverse effects , Mercuric Chloride/toxicity , Social Behavior , Adaptive Immunity/drug effects , Adaptive Immunity/genetics , Animals , Autoantibodies/blood , Autoimmunity/drug effects , Autoimmunity/genetics , Behavior, Animal/drug effects , Brain/drug effects , Brain/embryology , Brain/immunology , Cytokines/analysis , Cytokines/immunology , Female , Haplotypes , Immunity/genetics , Immunity, Innate/drug effects , Immunity, Innate/genetics , Immunoglobulin G/blood , Lactation , Male , Mercuric Chloride/pharmacokinetics , Mice , Mice, Inbred Strains , Milk/chemistry , Pregnancy , Sex Factors
13.
Basic Clin Pharmacol Toxicol ; 112(6): 412-7, 2013 Jun.
Article En | MEDLINE | ID: mdl-23302034

The toxicity of cinnabar, a naturally occurring mercury sulphide (HgS), has long been referred to soluble mercury chloride (HgCl2 ). To investigate whether the speciation of mercury plays a role in its disposition and toxicity, we hereby investigated and compared cinnabar with soluble HgCl2 and pure insoluble HgS in mice on mercury absorption, tissue distribution and in relation to the biological effects. The male C57BL/6J mice were treated by oral administration of various doses of cinnabar, with 0.01 g/kg of HgCl2 for comparison, or the same dose of cinnabar or pure HgS (0.1 g/kg), once a day for 10 consecutive days. The total mercury contents in serum and tissue (brain, kidney, liver) were measured by atomic fluorescence spectrometer (AFS). The biological effects investigated involved monoamine neurotransmitters (serotonin, 5-HT) in brain as an indicator of therapeutic function, and serum alanine transaminase (ALT) as a marker of hepatic damage, blood urea nitrogen (BUN) and serum creatinine as markers for renal function. The mercury absorption of cinnabar or HgS was much less than that of HgCl2 . The mercury levels in brains of the cinnabar group were only slightly changed and kept in a steady-state with the dose elevated. Cinnabar or HgS suppressed brain 5-HT levels. HgCl2 could not cause any changes in brain 5-HT although the mercury level increased considerably. The results revealed that cinnabar or HgS is markedly different from HgCl2 in mercury absorption, tissue distribution and influence on brain 5-HT levels, which suggests that the pharmacological and/or toxicological effects of cinnabar undertake other pathways from mercuric ions.


Brain/drug effects , Mercuric Chloride/pharmacokinetics , Mercury Compounds/pharmacokinetics , Serotonin/metabolism , Adsorption , Animals , Biomarkers/metabolism , Brain/metabolism , Dose-Response Relationship, Drug , Kidney/drug effects , Kidney/metabolism , Kidney Function Tests , Liver/drug effects , Liver/metabolism , Liver Function Tests , Male , Mercuric Chloride/administration & dosage , Mercuric Chloride/blood , Mercuric Chloride/toxicity , Mercury Compounds/administration & dosage , Mercury Compounds/blood , Mercury Compounds/toxicity , Mice , Mice, Inbred C57BL , Tissue Distribution
14.
Biomed Environ Sci ; 24(5): 550-9, 2011 Oct.
Article En | MEDLINE | ID: mdl-22108423

OBJECTIVE: This study aims to investigate the protection of procyanidins and lycopene from the renal damage induced by mercuric chloride. METHODS: Rats were treated with either procyanidins or lycopene 2h before HgCl(2) subcutaneously injection, once daily treatment for 2 successive days. RESULTS: In comparison with HgCl(2) group, markers of renal function such as blood urea nitrogen in serum and urinary protein were decreased to (18.45±11.63) mmol/L and (15.93±9.36) mmol/L, (4.54±0.78) g/(g·Cr) and (4.40±1.12) g/(g·Cr). N-acetyl-beta-D-glucosaminidase, lactate dehydrogenase, alkaline phosphatase in urine were depressed to (125.49±11.68) U/(g·Cr), (103.73±21.79) U/(g·Cr), (101.99±12.28) U/(g·Cr), and (113.19±23.74) U/(g·Cr), (71.14±21.80) U/(g·Cr), (73.64±21.51) U/(g·Cr) in procyanidins and lycopene groups. Indicators of oxidative stress, for example, Glutathion was reduced to (45.58±9.89) µmol/(g·pro) and (45.33±5.90) µmol/(g·pro), and antioxidant enzymes such as superoxide dismutase, glutathione-peroxidase were enhanced to (43.07±10.97) U/(mg·pro) and (39.94±6.04) U/(mg·pro), (83.85±18.48) U/(mg·pro), and (85.62±12.68) U/(mg·pro). Malondialdehyde was lowered to (0.95±0.12) (µmol/g·pro) and (1.03±0.12) µmol/(g·pro) in procyanidins and lycopene groups. ROS generation was decreased by 27.63% and 16.40% and apoptosis was also decreased in procyanidins and lycopene groups respectively. Pathological changes were much better as well. CONCLUSION: Procyanidins and Lycopene play some protective role against mercury kidney damage.


Antioxidants/therapeutic use , Carotenoids/therapeutic use , Kidney Diseases/prevention & control , Kidney/drug effects , Mercuric Chloride/toxicity , Proanthocyanidins/therapeutic use , Acetylglucosaminidase/urine , Alkaline Phosphatase/urine , Animals , Blood Urea Nitrogen , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Kidney/metabolism , Kidney/pathology , Kidney Diseases/chemically induced , Kidney Diseases/metabolism , Kidney Diseases/pathology , L-Lactate Dehydrogenase/urine , Lipid Peroxidation , Lycopene , Malondialdehyde/metabolism , Mercuric Chloride/pharmacokinetics , Mercuric Chloride/urine , Mercury/metabolism , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism
15.
J Toxicol Sci ; 36(3): 365-72, 2011 Jun.
Article En | MEDLINE | ID: mdl-21628964

Among the naturally occurring three mercury species, metallic mercury (Hg(0)), inorganic mercury (Hg(II)) and methylmercury (MeHg), Hg(II) is well documented to induce metallothionein (MT) in tissues of injected animals. Although Hg(0) and MeHg are considered to be inert in terms of directly inducing MT, MT can be induced by them after in vivo conversion to Hg(II) in an animal body. In the present study we examined accumulations of inorganic mercury and MT inductions in mouse tissues (brain, liver and kidney) up to 72 hr after treatment by one of three mercury compounds of sub-lethal doses. Exposure to mercury compounds caused significant mercury accumulations in mouse tissues examined, except for the Hg(II)-treated mouse brain. Although MeHg caused the highest total mercury accumulation in all tissues among mercury compounds, the rates of inorganic mercury were less than 10% through the experimental period. MT inductions that depended on the inorganic mercury accumulation were observed in kidney and brain. However, MT induction in the liver could not be accounted for by the inorganic mercury accumulation, but by plasma IL6 levels, marked elevation of which was observed in Hg(II) or MeHg-treated mouse. The present study demonstrated that MT was induced in mouse tissues after each of three mercury compounds, Hg(0), Hg(II) and MeHg, but the induction processes were different among tissues. The induction would occur directly through accumulation of inorganic mercury in brain and kidney, whereas the hepatic MT might be induced secondarily through mercury-induced elevation in the plasma cytokines, rather than through mercury accumulation in the tissue.


Environmental Pollutants/toxicity , Gene Expression/drug effects , Mercury Compounds/toxicity , Metallothionein/biosynthesis , Administration, Inhalation , Animals , Cerebellum/drug effects , Cerebellum/metabolism , Cerebrum/drug effects , Cerebrum/metabolism , Environmental Pollutants/pharmacokinetics , Interleukin-6/blood , Kidney/drug effects , Kidney/metabolism , Male , Mercuric Chloride/pharmacokinetics , Mercuric Chloride/toxicity , Mercury/pharmacokinetics , Mercury/toxicity , Mercury Compounds/pharmacokinetics , Metallothionein/genetics , Methylmercury Compounds/pharmacokinetics , Methylmercury Compounds/toxicity , Mice , Mice, Inbred C57BL , RNA, Messenger/metabolism
16.
J Neurosci Res ; 89(3): 320-8, 2011 Mar.
Article En | MEDLINE | ID: mdl-21259319

Some of the aquaporins (AQPs), a family of water channel proteins, are expressed in astrocytes. The expression of astrocytic AQPs is altered after brain insults, such as ischemia and head trauma. However, little is known about the regulation of AQP expressions. Endothelins (ETs), which are vasoconstrictor peptides, regulate several pathophysiological responses of astrocytes. In this study, the effects of ETs on AQP expressions and plasma membrane water permeability were examined in cultured rat astrocytes. Determination of AQP mRNA copy numbers revealed that AQP1 and AQP4 were expressed prominently in cultured astrocytes. ET-1 (100 nM) and Ala¹,³,¹¹,¹5-ET-1 (an ETB receptor agonist, 50 nM) decreased the AQP4 and AQP9 mRNA levels in cultured astrocytes, but the AQP1, -3, -5, and -8 mRNA levels remained unchanged. BQ788, an ETB receptor antagonist, reduced the effects of ET-1 on astrocytic AQP mRNAs, whereas FR139317, an ETA antagonist, had no effect. Immunoblot analyses revealed that treatment with ET-1 decreased the protein contents of AQP4 and AQP9 in both total cell lysates and plasma membrane fractions of cultured astrocytes. ET-1 and Ala¹,³,¹¹,¹5-ET-1 decreased hypoosmolarity-induced water influxes into cultured astrocytes. In the presence of 30 µM Hg²+, which inhibits water movement through AQP1 and AQP9, the hypoosmolarity-induced water influxes were reduced. Phloretin, an inhibitor of AQP9, did not greatly affect the water influxes. The ET-induced decreases in water influxes were obtained in the presence of Hg²+ and phloretin. These results suggest that ET is a factor that regulates AQP expressions and water permeability in astrocytes.


Aquaporins/metabolism , Astrocytes/cytology , Cell Membrane Permeability/drug effects , Cell Membrane/physiology , Endothelin-1/pharmacology , Gene Expression Regulation/drug effects , Water/metabolism , Analysis of Variance , Animals , Animals, Newborn , Aquaporins/genetics , Astrocytes/physiology , Brain/cytology , Cell Membrane Permeability/physiology , Cells, Cultured , Mercuric Chloride/pharmacokinetics , Phloretin/metabolism , RNA, Messenger/metabolism , Rats , Rats, Wistar , Time Factors
17.
Toxicol Lett ; 200(3): 194-200, 2011 Feb 05.
Article En | MEDLINE | ID: mdl-21126564

Cinnabar (HgS) is used in traditional medicines, and total Hg content is used for risk assessment of cinnabar-containing traditional medicines such as Zhu-Sha-An-Shen-Wan (ZSASW). Is ZSASW or cinnabar toxicologically similar to common mercurials? Adult Sprague-Dawley rats were gavaged with ZSASW (1.4 g/kg), cinnabar (0.2g/kg), HgCl(2) (0.02 g/kg), MeHg (0.001 g/kg), or saline daily for 60 days, and toxicity was determined. Animal body-weight gain was decreased by HgCl(2) and MeHg. Blood urea nitrogen (BUN) was increased by MeHg. Histology showed severe kidney injury following MeHg and HgCl(2) treatments, but mild after ZSASW and cinnabar. Renal Hg contents were markedly increased in the HgCl(2) and MeHg groups but were not elevated in the ZSASW and cinnabar groups. The expression of kidney injury molecule-1 was increased 50-fold by MeHg, 4-fold by HgCl(2), but was unaltered by ZSASW and cinnabar; the expression of matrilysin was increased 3-fold by MeHg. In contrast, the expression of N-cadherin was decreased by HgCl(2). Thus, ZSASW and cinnabar are much less nephrotoxic than HgCl(2) and MeHg, indicating that chemical forms of mercury underlie their disposition and toxicity.


Drugs, Chinese Herbal/toxicity , Mercuric Chloride/toxicity , Mercury Compounds/toxicity , Methylmercury Compounds/toxicity , Animals , Biomarkers/metabolism , Blood Chemical Analysis , Body Weight/drug effects , DNA Primers , Gene Expression/drug effects , Kidney/metabolism , Kidney/pathology , Kidney Diseases/chemically induced , Kidney Diseases/pathology , Male , Medicine, Chinese Traditional , Mercuric Chloride/pharmacokinetics , Mercury/metabolism , Mercury Compounds/pharmacokinetics , Mercury Poisoning/genetics , Mercury Poisoning/pathology , Methylmercury Compounds/pharmacokinetics , RNA/genetics , RNA/isolation & purification , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Weight Gain/drug effects
18.
Hum Exp Toxicol ; 30(11): 1777-84, 2011 Nov.
Article En | MEDLINE | ID: mdl-21148200

Chronic mercury exposure impairs vascular function, leading to the depression of endothelium-dependent vasodilatation. Loss of the nitric oxide (NO) pathway has been implicated, but little is known about effects on other endothelial mediators. This study investigated the mechanisms of endothelial dysfunction in rats subjected to chronic mercury chloride exposure. The endothelium-dependent relaxation of rat aorta evoked by acetylcholine (ACh) and isoproterenol was impaired in a dose-dependent manner by chronic mercury chloride exposure. Endothelium-independent responses to sodium nitroprusside (SNP) were not affected by chronic mercury chloride exposure. In healthy vessels, ACh-induced relaxation was inhibited by L-N-nitroarginine methyl ester (L-NAME; 10(-4) M) and partially by glybenclamide (10(-5) M), indicating the involvement of NO and endothelium-derived hyperpolarizing factor (EDHF). In vessels from mercury-exposed rats, responses to ACh were insensitive to L-NAME but were significantly reduced by glybenclamide, indicating selective loss of NO-mediated relaxation. In vessels from mercury-exposed rats, responses to ACh were partially restored after treatment with the antioxidant, superoxide dismutase (SOD) and catalase, this effect was not seen when aorta from exposed group was incubated with L-NAME along with SOD and catalase indicating selective loss of NO-mediated vasodilatation and with no affect the EDHF-mediated component of relaxation. The results imply that chronic mercury exposure selectively impairs the NO pathway as a consequence of oxidative stress, while EDHF is able to maintain endothelium-dependent relaxation at a reduced level.


Biological Factors/metabolism , Environmental Pollutants/toxicity , Mercuric Chloride/toxicity , Nitric Oxide/blood , Vascular Diseases/physiopathology , Vasodilation/drug effects , Acetylcholine/pharmacology , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiopathology , Endothelium, Vascular/drug effects , Endothelium, Vascular/injuries , Endothelium, Vascular/physiopathology , Environmental Pollutants/pharmacokinetics , Female , Glyburide/pharmacology , In Vitro Techniques , Isoproterenol/pharmacology , Male , Malondialdehyde/blood , Mercuric Chloride/pharmacokinetics , Mercury/blood , Muscle, Smooth/blood supply , Muscle, Smooth/drug effects , Muscle, Smooth/physiopathology , NG-Nitroarginine Methyl Ester/pharmacology , Nitroprusside/pharmacology , Rats , Rats, Wistar , Vascular Diseases/metabolism , Vasodilator Agents/pharmacology
19.
Chem Biol Interact ; 189(1-2): 134-40, 2011 Jan 15.
Article En | MEDLINE | ID: mdl-21094152

An-gong-niu-huang wan (AGNH) is a famous traditional Chinese medicine used for brain trauma, hemorrhage, and coma. AGNH contains 10% realgar (As4S4) and 10% cinnabar (HgS). Both As and Hg are well-known for their toxic effects, and the safety of AGNH is of concern. To address this question, the acute toxicity of AGNH, realgar and cinnabar were compared to sodium arsenite (NaAsO2) and mercuric chloride (HgCl2). Mice were administrated orally AGNH at 1, 3 and 6g/kg. AGNH at 3g/kg contains 2.8mmol As/kg as realgar and 1.18mmol Hg/kg as cinnabar. Realgar, cinnabar, arsenite (0.28 mmol/kg, 10% of realgar) and HgCl2 (0.256 mmol/kg, 20% of cinnabar) were orally given to mice for comparison. Blood and tissues were collected 8h later for toxicity evaluation. Serum alanine aminotransferase was increased by arsenite and blood urea nitrogen was increased by HgCl2. Total As accumulation after arsenite in liver (100-fold) and kidney (13-fold) was much higher than that after realgar. The accumulation of Hg after HgCl2 in liver was 400-fold higher and kidney 30-fold higher than after cinnabar. Histopathology showed moderate liver and kidney injuries after arsenite and HgCl2, but injuries were mild or absent after AGNH, realgar, and cinnabar. The expression of metallothionein-1, a biomarker of metal exposure, was increased 4-10-fold by arsenite and HgCl2, but was unchanged by AGNH, realgar and cinnabar. Thus, AGNH, realgar and cinnabar are much less toxic acutely than arsenite and HgCl2. The chemical forms of As and Hg are extremely important factors in determining their disposition and toxicity.


Medicine, Chinese Traditional , Mercury Compounds/toxicity , Sulfides/toxicity , Alanine Transaminase/blood , Animals , Arsenic/pharmacokinetics , Arsenicals/pharmacokinetics , Arsenites/pharmacokinetics , Arsenites/toxicity , Aspartate Aminotransferases/blood , Blood Urea Nitrogen , Creatinine/blood , Female , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Mercuric Chloride/pharmacokinetics , Mercuric Chloride/toxicity , Mercury/pharmacokinetics , Mercury Compounds/pharmacokinetics , Metallothionein/biosynthesis , Metallothionein/genetics , Mice , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Random Allocation , Reverse Transcriptase Polymerase Chain Reaction , Sodium Compounds/pharmacokinetics , Sodium Compounds/toxicity , Sulfides/pharmacokinetics
20.
J Toxicol Sci ; 35(5): 767-71, 2010 Oct.
Article En | MEDLINE | ID: mdl-20930471

To examine the neurotoxic action of inorganic mercury, HgCl(2) was injected in the intraventricular space of a mouse brain as a mimic for an Hg(0) vapor-exposed model, and the Hg distribution in the brain and behavioral changes were compared with those of Hg(0)-exposed mice. Although no difference was found in the Hg accumulation and its localization in the brains of two model mice at 3 weeks after Hg treatment, the turnover rate of the brain Hg in the Hg(0)-exposed mice was higher than in the Hg(II)-injected mouse. Despite a similar Hg level in the cerebrum at 3 weeks, behavioral alterations, hyper-activity in an open field test and shortening of latency in a passive avoidance test, were significant only in Hg(II)-injected mice. Considered together with the differences in the turnover rate and the effectiveness of neurotoxic action of the brain Hg, the microenvironment of Hg, such as biomolecules with which Hg interacts, might not be the same in both model mice. Inorganic Hg-induced neurotoxic action could be observed with a minimum dose of Hg(II) without any effects on the other organs, such as the kidney and lung. The present study demonstrated that intraventricular injection of HgCl(2) might be a convenient method to study the neurotoxic action of inorganic Hg, and, at least partly, to represent an animal model of Hg(0) vapor exposure.


Cerebral Ventricles/drug effects , Disease Models, Animal , Mercuric Chloride/toxicity , Mercury Poisoning, Nervous System/etiology , Animals , Behavior, Animal/drug effects , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Cerebral Ventricles/metabolism , Female , Inhalation Exposure , Injections, Intraventricular , Mercuric Chloride/pharmacokinetics , Mercury/pharmacokinetics , Mercury/toxicity , Mercury Poisoning, Nervous System/physiopathology , Mice , Mice, Inbred C57BL , Tissue Distribution , Volatilization
...